Analyst Consensus ?
ConsensusBuy20 ratings
Bullish1365.0%
Neutral735.0%
Bearish00.0%
Nordson Corporation · NDSN · FY2025 Q3 · Calendar Q3 2025
Nordson posts strong Q3 growth while flagging demand-timing risks
Nordson’s Q3 supports a constructive operating picture: growth in Advanced Technology Solutions, Atrion contribution and strong cash generation were paired with maintained guidance. The forward case still depends on demand timing, tariffs, industrial softness and execution on the divestiture.
Reported After market closeNASDAQIndustrials
$18.58B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.73
Consensus $2.64
EPS surprise
+3.4%
Reported versus consensus
Reported revenue
$741.5M
Consensus $723.6M
Revenue surprise
+2.5%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+3.0%
Event window
SPY move
-0.4%
Same window
Abnormal move
+3.4%
Stock minus SPY
Volume
4.8×
Versus trailing sessions
Subsequent drift
+2.3%
Up to 20 sessions
NDSNSPY benchmark
Ask FN2 about NDSN FY2025 Q3
Transcript, numbers and history already loaded
Why did NDSN rise 3.0% after beating EPS estimates in FY2025 Q3?What changed in NDSN's guidance and outlook in FY2025 Q3?Give me the bull and bear case for NDSN after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis adds a stronger Q3 outcome, record free cash flow, early EPS accretion from Atrion and a new share-repurchase authorization, while keeping full-year guidance maintained. It also highlights new product launches and a pending divestiture.
Guidance delta
Management maintained full-year guidance: revenue is expected slightly below the midpoint, while earnings are expected at or above the midpoint.
Key takeaways
- Q3 revenue growth was driven by double-digit organic growth in Advanced Technology Solutions and the Atrion acquisition.
- Record free cash flow supported debt reduction, dividends and share repurchases.
- Management maintained full-year guidance, with revenue slightly below the midpoint and earnings at or above it.
- New product launches and the medical contract manufacturing divestiture remain important execution items.
Management priorities
- Advance new products including Spectrum S2, PharmaLok Zero and the industrial-coatings control platform.
- Continue NBS Next product development and operational efficiency work.
- Complete the medical contract manufacturing divestiture while maintaining disciplined capital deployment.
Follow NDSN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$333.54Current
$240Low
$305.33Average
$375High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| DA Davidson | Buy | Buy | Maintain | Aug 24, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Aug 21, 2026 |
| Baird | Neutral | Neutral | Maintain | Aug 21, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Aug 20, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | May 22, 2026 |
| Loop Capital | Buy | Hold | Upgrade | Jan 22, 2025 |
| Seaport Global | Buy | Neutral | Upgrade | Dec 17, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 23, 2024 |
| Jefferies | Hold | Buy | Downgrade | Sep 26, 2023 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 9, 2022 |
| B. Riley Securities | Buy | Buy | Maintain | May 23, 2018 |
| B. Riley FBR | Buy | Buy | Maintain | May 23, 2018 |
| Gabelli & Co. | Hold | Buy | Downgrade | Dec 15, 2017 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 23, 2016 |
| Wunderlich Securities | Buy | Hold | Upgrade | Jan 7, 2016 |
| Wunderlich | Buy | Hold | Upgrade | Jan 7, 2016 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Dec 14, 2015 |
| BB&T Capital | Buy | Hold | Upgrade | Oct 10, 2014 |
| Barrington Research | Outperform | Market Perform | Upgrade | Jun 18, 2014 |
| BMO Capital | Market Perform | Outperform | Downgrade | May 24, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $333.54. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Industrial Alliance Securities | Analyst unavailable | $375 | $332.21 | +12.4% | Aug 24, 2026 |
| Oppenheimer | Analyst unavailable | $370 | $335.74 | +10.9% | Aug 21, 2026 |
| Robert W. Baird | Michael Halloran | $351 | $334.7 | +5.2% | Aug 21, 2026 |
| KeyBanc | Analyst unavailable | $360 | $309.92 | +7.9% | Aug 20, 2026 |
| Oppenheimer | Analyst unavailable | $335 | $287.66 | +0.4% | May 29, 2026 |
| D.A. Davidson | Analyst unavailable | $345 | $287.91 | +3.4% | May 27, 2026 |
| Oppenheimer | Analyst unavailable | $325 | $292.66 | -2.6% | Feb 24, 2026 |
| Jefferies | Saree Boroditsky | $300 | $289.98 | -10.1% | Feb 23, 2026 |
| D.A. Davidson | Analyst unavailable | $335 | $290.13 | +0.4% | Feb 23, 2026 |
| Robert W. Baird | Analyst unavailable | $314 | $293.93 | -5.9% | Feb 20, 2026 |
| KeyBanc | Analyst unavailable | $325 | $299.29 | -2.6% | Feb 19, 2026 |
| Vertical Research | Analyst unavailable | $270 | $237.37 | -19.1% | Dec 15, 2025 |
| D.A. Davidson | Analyst unavailable | $290 | $235.21 | -13.1% | Dec 12, 2025 |
| Robert W. Baird | Analyst unavailable | $275 | $234.45 | -17.6% | Dec 12, 2025 |
| KeyBanc | Jeffrey Hammond | $295 | $236.19 | -11.6% | Dec 11, 2025 |
| D.A. Davidson | Matthew Summerville | $285 | $239.06 | -14.6% | Oct 21, 2025 |
| Oppenheimer | Analyst unavailable | $275 | $225.79 | -17.6% | Aug 25, 2025 |
| Robert W. Baird | Analyst unavailable | $252 | $227.17 | -24.4% | Aug 22, 2025 |
| Jefferies | Analyst unavailable | $240 | $219.93 | -28.0% | Aug 21, 2025 |
| KeyBanc | Analyst unavailable | $260 | $206.55 | -22.0% | Mar 4, 2025 |
| Robert W. Baird | Michael Halloran | $287 | $256.03 | -14.0% | Aug 23, 2024 |
| Loop Capital Markets | Chris Dankert | $255 | $246.44 | -23.5% | May 22, 2024 |
| Robert W. Baird | Michael Halloran | $272 | $245.85 | -18.5% | May 22, 2024 |
| D.A. Davidson | Matthew Summerville | $295 | $243.14 | -11.6% | May 21, 2024 |
| D.A. Davidson | Matt Summerville | $270 | $232.33 | -19.1% | Aug 21, 2023 |
| KeyBanc | Jeffrey Hammond | $255 | $221.04 | -23.5% | Feb 22, 2023 |
| Robert W. Baird | Analyst unavailable | $271 | $239.17 | -18.8% | Aug 24, 2022 |
| Morgan Stanley | Analyst unavailable | $250 | $218.04 | -25.0% | Jun 9, 2022 |
| Berenberg Bank | Andrew Buscaglia | $300 | $222.06 | -10.1% | Jun 7, 2022 |
Track every rating change on NDSN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment.…
Historical context
All NDSN earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the NDSN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-04T10:20:42.491854+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-04T10:20:42.489027+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-04. For educational purposes only; not investment advice.